Unveiling miR-1468-5p: A New Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma

miR-1468-5p may serve as a useful patent as a therapeutic intervention target and a prognostic indicator for LUAD patients.

Authors

Yueyu Fang
Yi Chen
Dongbing Li (ORCID: https://orcid.org/0000-0002-5227-9643)

Institutions

Jiangsu Province Hospital (CN)
Nanjing Medical University (CN)

Publication Details

Journal: Recent Patents on Anti-Cancer Drug Discovery
Published: 2025-02-04
DOI: https://doi.org/10.2174/0115748928344326240927071620
Citations: 2
Primary Topic: Cancer-related molecular mechanisms research
Type: article
Field-Weighted Citation Impact: 1.87

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Unveiling miR-1468-5p: A New Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma

Yueyu Fang, Yi Chen, Dongbing Li

Feb 4, 2025

2 citations

Recent Patents on Anti-Cancer Drug Discovery

Cancer-related molecular mechanisms research

1.87

article

Unveiling miR-1468-5p: A New Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma

Yueyu Fang, Yi Chen, Dongbing Li

February 4, 2025article en

2 citations

Abstract

miR-1468-5p may serve as a useful patent as a therapeutic intervention target and a prognostic indicator for LUAD patients.

Recent Patents on Anti-Cancer Drug DiscoveryVol. 20(3)

Jiangsu Province Hospital (CN), Nanjing Medical University (CN)

Good health and well-being

Openalex Percentile: Top 17%

Cancer-related molecular mechanisms research

1.87

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Unveiling miR-1468-5p: A New Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma — Yueyu Fang, Yi Chen, et al. · Recent Patents on Anti-Cancer Drug Discovery (2025) | TGRS Research Map | TGRS